• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Rom J Intern Med . CT-scan Findings of COVID-19 Pneumonia Based on the Time Elapsed from the Beginning of Symptoms to the CT Imaging Evaluation: A D

tetano

Editor, Senior Moderator
Rom J Intern Med


. 2020 Jul 27;/j/rjim.ahead-of-print/rjim-2020-0019/rjim-2020-0019.xml.
doi: 10.2478/rjim-2020-0019. Online ahead of print.
CT-scan Findings of COVID-19 Pneumonia Based on the Time Elapsed from the Beginning of Symptoms to the CT Imaging Evaluation: A Descriptive Study in Iran


Sirous Jafari[SUP] 1 [/SUP], Mohammadreza Tabary[SUP] 2 [/SUP], Sahereh Eshraghi[SUP] 1 [/SUP], Farnaz Araghi[SUP] 3 [/SUP], Armin Aryannejad[SUP] 2 [/SUP], Esmaeil Mohammadnejad[SUP] 4 [/SUP], Mehrnaz Rasoolinejad[SUP] 1 [/SUP], Mahboubeh Hajiabdolbaghi[SUP] 1 [/SUP], Hamid Emadi Koochak[SUP] 1 [/SUP], Zahra Ahmadinejad[SUP] 1 [/SUP], Ladan Abbasian[SUP] 1 [/SUP], Seyed Ali Dehghan Manshadi[SUP] 1 [/SUP], Mohammadreza Salehi[SUP] 1 [/SUP], Hossein Khalili[SUP] 5 [/SUP], Niloofar Ayoobi Yazdi[SUP] 6 [/SUP], Arash Seifi[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Coronavirus disease 2019 (COVID-19) was initially detected in Wuhan city, China. Chest CT features of COVID-19 pneumonia have been investigated mostly in China, and there is very little information available on the radiological findings occurring in other populations. In this study, we aimed to describe the characteristics of chest CT findings in confirmed cases of COVID-19 pneumonia in an Iranian population, based on a time classification.
Methods: Eighty-nine patients with COVID-19 pneumonia, confirmed by a real-time RT-PCR test, who were admitted to non-ICU wards and underwent a chest CT scan were retrospectively enrolled. Descriptive evaluation of radiologic findings was performed using a classification based on the time interval between the initiation of the symptoms and chest CT-scan.
Results: The median age of patients was 58.0 years, and the median time interval from the onset of symptoms to CT scan evaluation was 7 days. Most patients had bilateral (94.4%) and multifocal (91.0%) lung involvement with peripheral distribution (60.7%). Also, most patients showed involvement of all five lobes (77.5%). Ground-glass opacities (GGO) (84.3%), and mixed GGO with consolidation (80.9%) were the most common identified patterns. We also found that as the time interval between symptoms and CT scan evaluation increased, the predominant pattern changed from GGO to mixed pattern and then to elongated-containing and band-like-opacities-containing pattern; on the other hand, the percentage of lung involvement increased.
Conclusions: Bilateral multifocal GGO, and mixed GGO with consolidation were the most common patterns of COVID-19 pneumonia in our study. However, these patterns might change according to the time interval from symptoms.

Keywords: COVID-19; Computed Tomography; Pneumonia; SARS-CoV-2.
 
Back
Top Bottom